Format

Send to

Choose Destination
Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Author information

1
Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
2
Laboratoire de Bactériologie, Inserm U853, Université de Bordeaux, Bordeaux, France.
3
Faculty of Health Sciences, Trinity College, Dublin, Ireland.
4
Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IP), Madrid, Spain.
5
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
6
Erasmus University Medical Center, Rotterdam, The Netherlands.
7
General Infirmary Leeds, UK.
8
Internal Medicine and Gastroenterology, University of Bologna Italy, Bologna, Italy.
9
Gastroenterology, and Liver Unit, Internal Medicine, Roma, Italy.
10
Nottingham, UK.
11
Department of Medicine (111D), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
12
Department of Medicine, McMaster University, Hamilton, Canada.
13
Hillcroft, Beaconsfield, Buckinghamshire, UK.
14
Department of Gastroenterology, McMaster University, Hamilton, Canada.
15
Department of Gastroenterology, Henry Dunant Hospital, Athens, Greece.
16
Department of Diagnostic Sciences, University of Padova, Padova, Italy.
17
Regensburg, Germany.
18
Medizinische Hochschule Hannover, Institut für Medizinische Mikrobiologie, Hannover, Germany.
19
Department of Medicine, Jichi Medical School, Tochigi, Japan.
20
St George and Sutherland Clinical School, University of New South Wales, Sydney, Australia.

Abstract

Important progress has been made in the management of Helicobacter pylori infection and in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role of H. pylori were re-evaluated in 2015. In the Maastricht V/Florence Consensus Conference, 43 experts from 24 countries examined new data related to H. pylori in five subdivided workshops: (1) Indications/Associations, (2) Diagnosis, (3) Treatment, (4) Prevention/Public Health, (5) H. pylori and the Gastric Microbiota. The results of the individual workshops were presented to a final consensus voting that included all participants. Recommendations are provided on the basis of the best available evidence and relevance to the management of H. pylori infection in the various clinical scenarios.

KEYWORDS:

GASTRITIS; HELICOBACTER PYLORI; HELICOBACTER THERAPY

PMID:
27707777
DOI:
10.1136/gutjnl-2016-312288
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center